Actualités Medincell SA - MEDCL | Actions Euronext

Votre Hub pour des idées et discussions en direct en temps réel

Medincell : Publication du calendrier financier 2025

Regulatory News: Medincell (Paris:MEDCL): Évènement Date Résultats annuels 2024-2025 (avril 2024-mars 2025) mardi 17 juin 2025 Assemblée Générale...

MedinCell : Information relative au nombre d’actions composant le capital social et au nombre total des droits de vote

Article 223-16 du règlement Général de l’Autorité des Marchés Financiers Regulatory News: MedinCell (Paris:MEDCL) : Place de cotation : Euronext...

Medincell to Join the Euronext SBF 120 Index

Regulatory News: Medincell (Paris:MEDCL) joins the Euronext SBF 120 index, which includes the 120 largest companies listed on Euronext Paris...

Medincell to Join the Euronext SBF 120 Index

Medincell (Paris:MEDCL) joins the Euronext SBF 120 index, which includes the 120 largest companies listed on Euronext Paris, including the CAC 40...

Medincell Publishes Its Consolidated Half-year Financial Results

(April 1st, 2024 - September 30, 2024) Regulatory News: Medincell (Paris:MEDCL): Key highlights Sales growth of UZEDY® in the United States €2.8...

Medincell and AIC Unveil New Positive Phase 3 Results for mdc-CWM: Major Subgroup Analysis Shows Reduced Pain and Opioid Use, and Accelerated Rehabilitation following Total Knee Replacement

Analysis of a major subgroup of patients undergoing a first Total Knee Replacement (TKR), representing over 70% of the trial population (108 out...

Medincell and AIC Unveil New Positive Phase 3 Results for mdc-CWM: Major Subgroup Analysis Shows Reduced Pain and Opioid Use, and Accelerated Rehabilitation following Total Knee Replacement

Regulatory News: Medincell (Paris:MEDCL): Analysis of a major subgroup of patients undergoing a first Total Knee Replacement (TKR), representing...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Medincell SA (MEDCL)

Votre Hub pour des idées et discussions en direct en temps réel

MEDCL Actualités

Medincell : Publication du calendrier financier 2025

MedinCell : Information relative au nombre d’actions composant le capital social et au nombre total des droits de vote

Medincell to Join the Euronext SBF 120 Index

Medincell to Join the Euronext SBF 120 Index

Medincell Publishes Its Consolidated Half-year Financial Results

Medincell and AIC Unveil New Positive Phase 3 Results for mdc-CWM: Major Subgroup Analysis Shows Reduced Pain and Opioid Use, and Accelerated Rehabilitation following Total Knee Replacement

Medincell and AIC Unveil New Positive Phase 3 Results for mdc-CWM: Major Subgroup Analysis Shows Reduced Pain and Opioid Use, and Accelerated Rehabilitation following Total Knee Replacement

Medincell : Vidéoconférence et publication des résultats financiers semestriels, mardi 10 décembre 2024

MedinCell : Information relative au nombre d’actions composant le capital social et au nombre total des droits de vote

Medincell: 25% Raise in 2024 UZEDY® Revenue Outlook & Key Milestone Reached for Olanzapine LAI Clinical Phase 3

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Medincell SA (MEDCL) Actualités

Medincell SA (MEDCL)

Votre Hub pour des idées et discussions en direct en temps réel

MEDCL Actualités

Medincell : Publication du calendrier financier 2025

MedinCell : Information relative au nombre d’actions composant le capital social et au nombre total des droits de vote

Medincell to Join the Euronext SBF 120 Index

Medincell to Join the Euronext SBF 120 Index

Medincell Publishes Its Consolidated Half-year Financial Results

Medincell and AIC Unveil New Positive Phase 3 Results for mdc-CWM: Major Subgroup Analysis Shows Reduced Pain and Opioid Use, and Accelerated Rehabilitation following Total Knee Replacement

Medincell and AIC Unveil New Positive Phase 3 Results for mdc-CWM: Major Subgroup Analysis Shows Reduced Pain and Opioid Use, and Accelerated Rehabilitation following Total Knee Replacement

Medincell : Vidéoconférence et publication des résultats financiers semestriels, mardi 10 décembre 2024

MedinCell : Information relative au nombre d’actions composant le capital social et au nombre total des droits de vote

Medincell: 25% Raise in 2024 UZEDY® Revenue Outlook & Key Milestone Reached for Olanzapine LAI Clinical Phase 3

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application